Enlivex Therapeutics Ltd. (FRA:1BT)
Germany · Delayed Price · Currency is EUR 0.6950
-0.0050 (-0.71%)
At close: Dec 19, 2025
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of €17.31 million as of December 22, 2025. Its market cap has decreased by -36.24% in one year.
Market Cap
17.31M
Enterprise Value
2.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.70
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 90.03M to 17.31M, a decrease of -80.78%. That is a compound annual growth rate of -21.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 17.31M | -30.35% |
| Dec 31, 2024 | 24.85M | -45.30% |
| Dec 29, 2023 | 45.43M | -33.03% |
| Dec 30, 2022 | 67.83M | -32.66% |
| Dec 31, 2021 | 100.74M | 1.56% |
| Dec 31, 2020 | 99.19M | 28.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |